Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC

CytoDyn, Inc. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
triple negative breast neoplasms, tnbc, pro 140, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 875804
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.